Consequences of COVID-19 Among Adult HIV Patients Versus Non-HIV Patients: Two-Year Data From the Primary Isolation Centre in Sudan.

Abstract

Background The COVID-19 pandemic remains to have a global impactdespite the great efforts in prevention.Controversy persists regarding the outcomes of SARS-CoV-2 among HIV patientsversus non-HIV individuals. Objective This study aimed to assess the impact of COVID-19among adult patients with HIV versus non-HIV in the chief isolation centre in Khartoum state, Sudan. Methods This is an analytical cross-sectional, comparative single-centre study conducted at the Chief Sudanese Coronavirus Isolation Centre in Khartoum from March 2020 to July 2022.Data were analysed using SPSS V.26 (IBM Corp., Armonk, USA). Results This study included 99 participants. The overall age mean was 50±1 years old, with a male predominance of 66.7% (n=66).9.1% (n=9) of the participants were HIV cases, 33.3% of whom were newly diagnosed.The majority, 77.8%,reported poor adherence to anti-retroviral therapy.The most common complications included acute respiratory failure (ARF) and multiple organ failure, 20.2% and 17.2%, respectively. The overall complicationswere higher among HIV cases than non-HIV cases; however, statistically insignificant (p>0.05 ), except for acute respiratory failure (p<0.05). 48.5% of participants were admitted to the intensive care unit (ICU), with slightly higher rates among HIV cases; however, this was statistically insignificant (p=0.656). Regarding the outcome, 36.4% (n=36) recovered and were discharged.Although a higher mortality rate was reported among HIV cases compared to non-HIV cases (55% vs 40%),it was statistically insignificant (p=0.238). Conclusion Themortality and morbidity percent proportion among HIV patients with superimposed COVID-19 infection was higher than in non-HIV patients but statistically insignificant aside from ARF.Consequently, this category of patients, to a large extent, should not be considered highly susceptible to adverse outcomes when infected with COVID-19; however, ARF should be closely monitored for.